Soapstone Management’s Chemours CC Stock Holding History

Soapstone Management’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-125,000	Closed	-$2.26M	–	16
2019 Q4	$2.26M	Sell	125,000 -10,000	-7%	-$166K	1.44%	14
2019 Q3	$2.02M	Hold	135,000	–	–	1.1%	15
2019 Q2	$3.24M	Buy	135,000 +10,000	+8%	+$295K	1.76%	14
2019 Q1	$4.64M	Buy	125,000 +40,000	+47%	+$1.46M	2.27%	13
2018 Q4	$2.4M	Buy	+85,000	New	+$2.69M	1.44%	16

Other funds holding CC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Soapstone Management's CC Position: Q1 2020 in Review

Soapstone Management sold out of Chemours (CC) in Q1 2020, closing a stake of 125,000 shares — an estimated $2.26M sold.

Soapstone Management first reported a position in CC in Q4 2018 and held it in 5 quarters. The position peaked at $4.64M in Q1 2019. 416 funds tracked by Wall St. Rank hold CC as of Q1 2020.

Soapstone Management reported no remaining Chemours position as of Q1 2020 after selling out during the quarter.
Soapstone Management sold 125,000 Chemours shares in Q1 2020, an estimated $2.26M.
Soapstone Management first reported a position in Chemours in Q4 2018 and held it in 5 quarters.
Soapstone Management's Chemours position peaked at $4.64M in Q1 2019.
416 funds tracked by Wall St. Rank held Chemours as of Q1 2020.

Based on Soapstone Management's 13F filing for Q1 2020, filed 15 May 2020.